Prolonged Central Nervous System Response in a Patient With HER2 Mutant NSCLC Treated With First-Line Poziotinib

Detalles Bibliográficos
Autores principales: Tchekmedyian, Nishan, Paxton, Bill, Lebel, Francois, Keossayan, Lena, Heymach, John V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474396/
https://www.ncbi.nlm.nih.gov/pubmed/34589960
http://dx.doi.org/10.1016/j.jtocrr.2020.100081
_version_ 1784575207618379776
author Tchekmedyian, Nishan
Paxton, Bill
Lebel, Francois
Keossayan, Lena
Heymach, John V.
author_facet Tchekmedyian, Nishan
Paxton, Bill
Lebel, Francois
Keossayan, Lena
Heymach, John V.
author_sort Tchekmedyian, Nishan
collection PubMed
description
format Online
Article
Text
id pubmed-8474396
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-84743962021-09-28 Prolonged Central Nervous System Response in a Patient With HER2 Mutant NSCLC Treated With First-Line Poziotinib Tchekmedyian, Nishan Paxton, Bill Lebel, Francois Keossayan, Lena Heymach, John V. JTO Clin Res Rep Case Report Elsevier 2020-08-07 /pmc/articles/PMC8474396/ /pubmed/34589960 http://dx.doi.org/10.1016/j.jtocrr.2020.100081 Text en © 2020 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Tchekmedyian, Nishan
Paxton, Bill
Lebel, Francois
Keossayan, Lena
Heymach, John V.
Prolonged Central Nervous System Response in a Patient With HER2 Mutant NSCLC Treated With First-Line Poziotinib
title Prolonged Central Nervous System Response in a Patient With HER2 Mutant NSCLC Treated With First-Line Poziotinib
title_full Prolonged Central Nervous System Response in a Patient With HER2 Mutant NSCLC Treated With First-Line Poziotinib
title_fullStr Prolonged Central Nervous System Response in a Patient With HER2 Mutant NSCLC Treated With First-Line Poziotinib
title_full_unstemmed Prolonged Central Nervous System Response in a Patient With HER2 Mutant NSCLC Treated With First-Line Poziotinib
title_short Prolonged Central Nervous System Response in a Patient With HER2 Mutant NSCLC Treated With First-Line Poziotinib
title_sort prolonged central nervous system response in a patient with her2 mutant nsclc treated with first-line poziotinib
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474396/
https://www.ncbi.nlm.nih.gov/pubmed/34589960
http://dx.doi.org/10.1016/j.jtocrr.2020.100081
work_keys_str_mv AT tchekmedyiannishan prolongedcentralnervoussystemresponseinapatientwithher2mutantnsclctreatedwithfirstlinepoziotinib
AT paxtonbill prolongedcentralnervoussystemresponseinapatientwithher2mutantnsclctreatedwithfirstlinepoziotinib
AT lebelfrancois prolongedcentralnervoussystemresponseinapatientwithher2mutantnsclctreatedwithfirstlinepoziotinib
AT keossayanlena prolongedcentralnervoussystemresponseinapatientwithher2mutantnsclctreatedwithfirstlinepoziotinib
AT heymachjohnv prolongedcentralnervoussystemresponseinapatientwithher2mutantnsclctreatedwithfirstlinepoziotinib

Ejemplares similares